1)Antoch G, Saoudi N, Kuehl H et al:Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography(FDG_PET/CT)for tumor staging in solid tumors:comparison with CT and PET. J Clin Oncol 22:4357-4368, 2004
2)康純 明・村田哲洋・渋谷雅常・他:所属リンパ節にサルコイド反応を伴った肝細胞癌の1例.日消外会誌 40:271-276,2007
3)Brincker H:Sarcoid reactions in malignant tumours. Cancer Treat Rev 13:147-156, 1986
F FDG-PET/CTの役割.臨床放射線 55:155-162,2010
5)Kubota R, Yamada S, Kubota K et al:Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo:high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972-1980, 1992
6)Hunt BM, Vallieres E, Buduha G et al:Sarcoidosis as a benign cause of lymphadenopathy in cancer patient. Am J Surg 197:629-632, 2009
Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47:1571-1576, 2006
Ga-citrate in sarcoidosis imaging. Nuklearmedizin 47:18-23, 2008
9)Seve P, Grange JD, Kodjikian L et al:Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis. Ocul Immunol Inflamm 17:179-184, 2009
10)日本眼炎症学会・日本サルコイドーシス/肉芽腫性疾患学会:サルコイドーシスの診断基準と診断の手引き―2006.日眼会誌 111:117-121,2007